text.skipToContent text.skipToNavigation
Need help? Please contact us
You searched for "cryopreserved bone marrow"
Too many choices? Use the filter option on the left to narrow your product listing.
1-10 of 732 results
61-70 of 1091 results
  • Transfection Protocol for Immature mouse DC (C57BL/6) - 4D-Nucleofector™ Device
    Instructions of use for transfection of immature mouse dendritic cells (C57BL/6) with the P4 Primary Cell 4D-Nucleofector™ X Kit
  • Transfection Protocol for Mature Mouse DC (BALB/c) - 4D-Nucleofector™ Device
    Instructions of use for transfection of mature mouse dendritic cells (BALB/c) with the P3 Primary Cell 4D-Nucleofector™ X Kit
  • Bioscience Solutions - Providing Industry-Leading Research, Discovery and Manufacturing Tools (English)
    Lonza_Brochures_Providing_Industry-Leading_Research_Discovery_and_Manufacturing_Tools_English.pdf
  • Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force Awakens
    Poster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
  • Cell List – Integrated Solutions for Primary Cells and Transfection
  • Instruction Lymphocyte Separation Medium
    Short instruction how to use LSM (17-829)
  • FlashGel® System - Citations
    Lonza Product Citation List FlashGel System
  • Primary and Stem Cell Applications for Diabetes and Obesity Research
    Webinar - PDF Version
  • Easy and Efficient Nucleofection of Cryopreserved Dissociated Adult Rat Vascular Smooth Muscle Cells: New Opportunities for Vascular Research
    The ready-to-use advantage of batch tested, cryopreserved dissociated rodent neuronal cells, combined with the high quality, high-throughput transfection of these cells using the4D-Nucleofector™ System, offers a convenient, effective and time-saving approach for researchers employing genetically modified strategies for their R&D programs.
  • CAR T cells in Cancer Therapy
    A poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.